Novel inactivating mutations of transforming growth factor-β type I receptor gene in head-and-neck cancer metastases

International Journal of Cancer

Volumn 93, Issue 5, 2001, Pages 653-661

  Chen, Taiping ^a   Yan, Wu ^a   Wells, Rebecca G ^a   Rimm, David L ^a   McNiff, Jennifer ^a   Leffell, David ^a   Reiss, Michael ^a,b  

^a YALE CANCER CENTER   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Head and neck cancer; Mutation; Transforming growth factor receptor

Indexed keywords

PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; EPITHELIUM TUMOR; GENE INACTIVATION; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; METASTASIS; MINK; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR GENE;

ACTIVIN RECEPTORS, TYPE I; AMINO ACID SEQUENCE; DISEASE PROGRESSION; ENDOPLASMIC RETICULUM; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASMS, UNKNOWN PRIMARY; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035452460     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1381     Document Type: Article

References (49)

1. Regulation of growth and differentiation of human keratinocytes by type β transforming growth factor and epidermal growth factor
2. Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum-free medium
3. TGFβ signaling from cell membrane to nucleus through SMAD proteins
4. TGFβ signal transduction
5. Smads: Transcriptional activators of TGF-β responses
6. Latent transforming growth factor-beta: Structural features and mechanisms of activation
7. The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis
8. TGFβ and cancer
9. Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis
10. Genetic events and the role of TGFβ in epithelial tumour progression
11. The role of transforming growth factor-β receptors in cancer of the upper aero-digestive tract
12. TGFβ1 inhibits the formation of benign skin tumors but enhances progression to invasive spindle cell carcinomas in transgenic mice
13. Expression of a dominant-negative type II TGFβ receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development
14. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor β receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene
15. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas
16. Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFβRII
17. Expression of a dominant-negative type II transforming growth factor β (TGFβ) receptor in the epidermis of transgenic mice blocks TGFβ-mediated growth inhibition
18. Autocrine production of TGF-alpha and TGF-beta during tumour progression of rat oral keratinocytes
19. TGF-beta 1 and skin carcinogenesis: Antiproliferative effect in vitro and TGF-beta mRNA expression during epidermal hyperproliferation and multistage tumorigenesis
20. High frequency of resistance of human squamous carcinoma cells to the anti-proliferative action of transforming growth factor-β
21. Functional characterization of transforming growth factor beta type II receptor mutants in human cancer
22. Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells
23. Transfer of chromosome 18 into human head and neck squamous carcinoma cells: Evidence for tumor suppression by Smad4/DPC4
24. Smad protein expression and activation in transforming growth factor-β-refractory human squamous cell carcinoma cells
25. Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck
26. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma
27. Transforming growth factor-β type I receptor kinase mutant associated with metastatic breast cancer
28. Structural alterations of transforming growth factor-β receptor genes in cervical carcinoma
29. Cloning and genomic organization of the human transforming growth factor-β type I receptor gene
30. Cloning of a TGFβ type I receptor that forms a heterodimeric complex with the TGFβ type II receptor
31. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin
32. TGFβ signals through a heteromeric protein kinase receptor complex
33. INK4B through an Sp1 consensus site
34. Biosynthesis of the type I and type II TGF-beta receptors. Implications for complex formation
35. Tumor suppressor activity of the TGF-beta pathway in human cancers
36. Transforming growth factor-beta and cancer: A love-hate relationship?
37. A deletion in the gene for transforming growth factor beta Type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma
38. Processing of the transforming growth factor beta type I and II receptors. Biosynthesis and ligand-induced regulation
39. Control of protein exit from the endoplasmatic reticulum
40. The relationship between sequence and structure in elementary folding units
41. Structural basis of an embryonically lethal single Ala→Thr mutation in the vnd/NK-2 homeodomain
42. Crystal structure of the cytoplasmic domain of the type I TGFβ receptor in complex with FKBP12
43. Protein kinase catalytic domain sequence database: Identification of conserved features of primary structure and classification of family members
44. Structural framework for the protein kinase family
45. Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency
46. TβR-I(6A) is a candidate tumor susceptibility allele
47. Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract
48. The S387Y mutations of the transforming growth factor-beta receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma
49. Abnormalities in expression of genes, mRNA, and proteins of transforming growth factor-beta receptor type I and type II in human pituitary adenomas